Cover Image
市場調查報告書

全球產前檢查、新生兒篩檢市場 2016-2022年

Global Prenatal Testing and Newborn Screening Market 2016-2022

出版商 BIS Research 商品編碼 351053
出版日期 內容資訊 英文 150 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球產前檢查、新生兒篩檢市場 2016-2022年 Global Prenatal Testing and Newborn Screening Market 2016-2022
出版日期: 2016年02月01日 內容資訊: 英文 150 Pages
簡介

全球產前檢查、新生兒遺傳基因檢驗市場規模今後預計將高成長,至預測期間末將超過106億3,000萬美元。由於次世代定序、高通量篩檢,及無細胞胎兒DNA等先進技術的登場,新開發的產前診斷、新生兒篩檢檢驗的整體需求慢慢增加。

本報告提供全球產前檢查、新生兒篩檢市場相關調查分析,市場促進要素,課題及機會與利用案例,最新技術,政府的法規,各地區的趨勢,及主要企業簡介等彙整,為您概述為以下內容。

第1章 調查概要

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 計劃
  • 全球產前檢查、新生兒篩檢市場生態系統企業
  • 以人種為基礎的Carrier的頻率
  • 產前、新生兒檢驗的指標
  • 產前檢查、新生兒篩檢的優點和風險
  • 市場動態

第4章 競爭考察

  • 主要市場發展、策略
  • 波特的五力分析

第5章 產業分析

  • 團體、國際集團及法規機關
  • 專利分析
  • 價值鏈分析

第6章 全球產前檢查市場

  • 簡介
  • 市場考察
  • 胎兒的遺傳基因疾病的種類:概要
  • 市場統計
  • 產前檢查市場:各技術
  • 妊娠中的產前檢查計劃
  • NIPT:主要的考察
  • 產前檢查技術:以技術為基礎的區分
  • 近幾年的發展 & 主要企業

第7章 全球新生兒篩檢檢驗市場

  • 市場考察、統計
  • 市場統計
  • 以新生兒篩檢為對象的疾病
  • 新生兒篩檢的標準流程
  • 近幾年的發展、主要企業

第8章 全球產前檢查、新生兒篩檢市場:各地區

  • 地區性的情形
  • 市場統計
  • 北美
  • 歐洲
  • 亞太地區 (APAC)
  • 其他 (ROW)

第9章 全球產前檢查、新生兒篩檢市場:主要企業

  • ILLUMINA, INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • NATUS MEDICAL INCORPORATED
  • PERKINELMER, INC.
  • QUEST DIAGNOSTICS INC.
  • 其他新興企業

圖表清單

目錄
Product Code: MD08

With the emergence of advanced technologies such as next generation sequencing, high throughput screening (HTS), and cell free fetal DNA, there has been a rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests. Presently, the main focus of the government initiatives is mainly towards developing non-invasive solutions, launching large number of newborn screening programs, controlling the increasing level of genetic disorders, and integrating advanced technologies to fulfill the unmet needs of the patients.

Governmental regulations and standards are playing a major role in sustaining the growth and development of the market. The main aim of these regulations is to make prenatal tests and solutions more adaptable and focused towards effective diagnosis of various genetic disorders & chromosomal abnormalities. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive accurate and proper diagnosis & screening of the disease.

This study includes an overview and analysis of the prenatal and newborn genetic testing market, by type of tests, techniques, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The prenatal and newborn genetic testing market report presents a detailed analysis of market dynamics and provides an extensive insight into various forms of developments, trends and key participants. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC), and Rest of the World (ROW).

The answers to the following key questions can be found in the report:

  • What are the major market drivers, challenges and opportunities of the prenatal testing and newborn screening market and their use cases?
  • What are the key trends and developments in the prenatal testing and newborn screening market for genetic disease management?
  • What are the key developmental strategies in different applications across all regions?
  • What are different types of prenatal tests and newborn screening methods and the latest technologies entering the market?
  • How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launches among others?
  • Which geographical region will lead the global prenatal testing and newborn screening market by the end of the forecast period?
  • Who are the key players in the prenatal testing and newborn screening market?
  • What are the key government regulations for different prenatal testing and newborn screening solutions?
  • What are the key market trends and key developments in different geographical regions?
  • What are the genetic disorders detectable by different prenatal screening and diagnostic tests?
  • What are the appropriate technologies for the detection of aneuploidies, micro-deletions, duplications, copy number variations and translocations?
  • What different noninvasive and invasive prenatal screening tests are performed during a pregnancy?
  • What is the global and regional market for newborn screening tests, through 2022?
  • What is the global market for newborn screening tests by technology, through 2022?
  • What are the detection rate, true positive rate and true negative rate for common NIPTs?
  • What is the global and regional market for NIPTs using cell free fetal DNA, through 2022?
  • How many genetic conditions are detected during newborn genetic screening in the U.S.?
  • What is the status of newborn genetic screening in developed, developing and other countries?
  • What are the currently used advanced technologies in prenatal and newborn testing?

While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, as well as their involvement in the prenatal and newborn genetic testing market. The research incorporates Porter's Five Force Model for an in-depth analysis of the prenatal and newborn genetic testing market and an assessment of the factors governing it. The analysis builds on a well-compiled value chain giving a detailed understanding of the ecosystem players and their market penetration.

The report includes the profiles of major players in the prenatal testing and newborn screening market that allows the readers to gain an insight into the various industry trends.

EXECUTIVE SUMMARY

Prenatal Testing and Newborn Screening is one of the most modernized trends in the healthcare industry which has shown a tremendous level of progress in the last few years. The growth of prenatal and newborn genetic testing market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, and advancement of healthcare technologies. The global prenatal and newborn genetic testing market has a high growth potential in future and will grow over $10.63 billion by the end of forecast period. With the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA, there has been a gradual rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests.

Factors such as legal approval of the prenatal testing and newborn screening in most of the states of the U.S. government investment & regulations, and healthcare policies of other developed and emerging countries are contributing to the overall market growth.

The report has been further classified into prenatal testing and newborn screening. Prenatal testing further segmented on the basis of techniques (diagnostic & screening) and nature of the test (invasive & non-invasive). Prenatal testing is dominating the market and growing at a CAGR of 27.98% from 2016 to 2022.

Diagnosis technologies are holding the maximum market share and are expected to grow at 26.54% CAGR from 2016 to 2022. The techniques can either be invasive and non-invasive. By studying the current trends, it can be said that non-invasive prenatal testing are gaining more traction from the patients. Lifestyle preferences such as smoking, drinking, obesity, increasing maternity age, and genetic disorders are some of the factors responsible for the growth of the market.

North America is the largest contributor in the overall revenue generation in prenatal and newborn care, followed by the European region, and is expected to grow at a CAGR of 23.36% from 2016 to 2022. While the U.S., the U.K., Japan, and India show a dynamic growth in the overall market due to an increasing prevalence of genetic disorders in these countries. Moreover, APAC region is focusing more on technological developments and introduction of new advanced tools in the field of prenatal and newborn care in order to develop specific tests and solutions.

COUNTRIES COVERED

North America, Europe, APAC, ROW (Middle East, Africa & South America)

Table of Contents

1. REPORT OVERVIEW

  • 1.1 REPORT SCOPE & REPORT COVERAGE
    • 1.1.1 MARKET SEGMENTATION
  • 1.2 RESEARCH METHODOLOGY
    • 1.2.1 DATA TRIANGULATION
    • 1.2.2 TOP-DOWN APPROACH
    • 1.2.3 BOTTOM-UP APPROACH
    • 1.2.4 ASSUMPTIONS & LIMITATIONS
  • 1.3 KEY DATA POINT SOURCES
    • 1.3.1 KEY DATA POINTS FROM SECONDARY SOURCES
    • 1.3.2 KEY DATA POINTS FROM PRIMARY SOURCES
  • 1.4 REPORT DESCRIPTION

2. EXECUTIVE SUMMARY

  • 2.1 GLOBAL MARKET SCENARIO

3. MARKET OVERVIEW

  • 3.1 INTRODUCTION
  • 3.2 TIMELINE
  • 3.3 ECOSYSTEM PLAYERS OF GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET
  • 3.4 CARRIER FREQUENCIES BASED ON ETHNIC ORIGIN
  • 3.5 INDICATIONS FOR PRENATAL AND NEWBORN TESTING
  • 3.6 BENEFITS AND RISKS OF PRENATAL TESTING & NEWBORN SCREENING
  • 3.7 MARKET DYNAMICS
    • 3.7.1 MARKET DRIVERS
    • 3.7.2 MARKET CHALLENGES
    • 3.7.3 MARKET OPPORTUNITIES

4 COMPETITIVE INSIGHTS

  • 4.1 KEY MARKET DEVELOPMENT & STRATEGIES
  • 4.2 PORTER'S FIVE FORCES ANALYSIS
    • 4.2.1 BARGAINING POWER OF BUYERS
    • 4.2.2 BARGAINING POWER OF SUPPLIER
    • 4.2.3 THREAT FROM SUBSTITUTE
    • 4.2.4 THREAT OF NEW ENTRANT
    • 4.2.5 INTENSITY OF COMPETITIVE RIVALRY

5 INDUSTRY ANALYSIS

  • 5.1 ASSOCIATIONS, CONSORTIUM AND REGULATORY BODIES
  • 5.2 PATENT ANALYSIS
  • 5.3 VALUE CHAIN ANALYSIS

6 GLOBAL PRENATAL TESTING MARKET

  • 6.1 INTRODUCTION
  • 6.2 MARKET INSIGHTS
  • 6.3 TYPES OF GENETIC DISEASES IN FETUSES: AN OVERVIEW
  • 6.4 MARKET STATISTICS
  • 6.5 PRENATAL TESTING MARKET BY TECHNIQUES
    • 6.5.1 SCREENING METHODS
    • 6.5.2 DIAGNOSIC TECHNIQUES
  • 6.6 PRENATAL TESTING TIMELINE DURING PREGNANCY
  • 6.7 NIPT: KEY INSIGHTS
  • 6.8 PRENATAL TESTING TECHNIQUES: SEGMENTATION ON THE BASIS OF TECHNOLOGY
  • 6.9 RECENT DEVELOPMENTS & KEY PLAYERS

7 GLOBAL NEWBORN SCREENING TESTING MARKET

  • 7.1 MARKET INSIGHTS & STATISTICS
  • 7.2 MARKET STATISTICS
  • 7.3 TARGETED DISORDERS IN NEWBORN SCREENING
  • 7.4 STANDARD PROCESSS IN NEWBORN SCREENING
  • 7.5 RECENT DEVELOPMENTS & KEY MARKET PLAYERS

8 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET BY GEOGRAPHY

  • 8.1 GEOGRAPHICAL SCENARIO
  • 8.2 MARKET STATISTICS
  • 8.3 NORTH AMERICA
    • 8.3.1 NORTH AMERICA: MARKET STATISTICS
    • 8.3.2 THE U.S.
    • 8.3.3 RECENT DEVELOPMENTS & KEY MARKET PLAYER
  • 8.4 EUROPE
    • 8.4.1 EUROPE: MARKET STATISTICS
    • 8.4.2 EUROPE: MARKET STATISTICS OF KEY COUNTRIES
    • 8.4.3 RECENT DEVELOPMENTS & KEY MARKET PLAYERS
  • 8.5 ASIA-PACIFIC (APAC)
    • 8.5.1 APAC: INSIGHTS & MARKET STATISTICS
    • 8.5.2 APAC: MARKET STATISTICS
    • 8.5.3 CHINA: MARKET STATISTICS
    • 8.5.4 INDIA: MARKET STATISTICS
    • 8.5.5 RECENT DEVELOPMENTS & KEY PLAYERS
  • 8.6 REST OF THE WORLD (ROW)
    • 8.6.1 ROW: MARKET STATISTICS
    • 8.6.2 MIDDLE EAST: KEY INSIGHTS

9 GLOBAL PRENATAL TESTING & NEWBORN SCREENING: KEY PLAYERS

  • 9.1 ILLUMINA, INC.
    • 9.1.1 SUMMARY & FINANCIALS
    • 9.2.2 KEY DEVELOPMENTS
    • 9.2.3 SWOT ANALYSIS
  • 9.2 LABORATORY CORPORATION OF AMERICA HOLDINGS
    • 9.2.1 SUMMARY & FINANCIALS
    • 9.2.2 KEY DEVELOPMENTS
    • 9.2.3 SWOT ANALYSIS
  • 9.3 NATUS MEDICAL INCORPORATED
    • 9.3.1 SUMMARY & FINANCIALS
    • 9.3.2 KEY DEVELOPMENTS
    • 9.3.3 SWOT ANALYSIS
  • 9.4 PERKINELMER, INC.
    • 9.4.1 SUMMARY & FINANCIALS
    • 9.4.2 KEY DEVELOPMENTS
    • 9.4.3 SWOT ANALYSIS
  • 9.5 QUEST DIAGNOSTICS INC.
    • 9.5.1 SUMMARY & FINANCIALS
    • 9.5.2 KEY DEVELOPMENTS
    • 9.5.3 SWOT ANALYSIS
  • 9.6 OTHER EMERGING PLAYERS

List of Figures

  • 1 RESEARCH METHODOLOGY
  • 2 YEAR CONSIDERATION FOR REPORT
  • 3 GLOBAL PRENATAL TESTING & NEWBORN SCREENING GENETIC TESTING MARKET ($BILLION)
  • 4 GLOBAL PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 5 GLOBAL PRENATAL & NEWBORN GENETIC TESTING MARKET SHARE, BY GENETIC TEST, 2015-2022 ($BILLION)
  • 6 GLOBAL PRENATAL & NEWBORN GENETIC TESTING MARKET SHARE, BY TECHNIQUES, 2015-2022 ($BILLION)
  • 7 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2015 - 2022 ($BILLION)
  • 8 TIMELINE SHOWING INCREASING NUMBER OF DISORDERS SCREENED IN A TEST
  • 9 INDICATIONS FOR PRENATAL AND NEWBORN TESTING
  • 10 MARKET DYNAMICS
  • 11 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET COMPETITIVE INSIGHTS
  • 12 PORTER'S FIVE FORCES ANALYSIS
  • 13 VALUE CHAIN ANALYSIS
  • 14 EXAMPLE OF SOME COMMON ACTS
  • 15 LIVE BIRTH RATE - RISK OF GENETIC ABNORMALITY/DISORDERS BY MATERNAL AGE
  • 16 ABILITY OF DIAGNOSTIC & SCREENING TECHNICHES TO DETECT GENETIC DISORDER
  • 17 GLOBAL PRENATAL TESTING MARKET, 2015-2022 ($BILLION)
  • 18 GLOBAL PRENATAL TESTING MARKET, BY TECHNIQUES -2015
  • 19 GLOBAL PRENATAL TESTING MARKET, BY NATURE OF TEST -2015
  • 20 GLOBAL PRENATAL TESTING MARKET, BY TECHNIQUES, 2015-2022 ($BILLION)
  • 21 GLOBAL PRENATAL TESTING MARKET, BY NATURE OF TEST, 2015-2022 ($BILLION)
  • 22 GLOBAL PRENATAL TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($BILLION)
  • 23 GLOBAL PRENATAL TESTING MARKET, BY GEOGRAPHY -2015
  • 24 GLOBAL PRENATAL TESTING MARKET, BY SCREENING METHODS, 2015-2022 ($BILLION)
  • 25 BENEFITS OF SCREENING METHODS
  • 26 GLOBAL PRENATAL TESTING MARKET, BY DIAGNOSTIC TECHNIQUES, 2015-2022 ($BILLION)
  • 27 BENEFITS OF DIAGNOSTIC TECHNIQUES
  • 28 PRENATAL TESTING TIMELINE DURING PREGNANCY (TILL SECOND TRIMESTER)
  • 29 DIAGNOSTIC TECHNIQUES BY INVASIVE TECHNOLOGY
  • 30 GLOBAL PRENATAL TESTING MARKET, BY TECHNOLOGY-2015
  • 31 GLOBAL NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 32 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2015-2022 ($BILLION)
  • 33 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY -2015
  • 34 TARGETED DISORDERS IN NEWBORN SCREENING
  • 35 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET-2015
  • 36 GLOBAL PRENATAL & NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2015-2022 ($BILLION)
  • 37 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET, BY GEOGRAPHY (2015)
  • 38 NORTH AMERICA PRENATAL TESTING & NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 39 NORTH AMERICA PRENATAL TESTING & NEWBORN SCREENING MARKET, BY SUB-REGION, 2015-2022 ($BILLION)
  • 40 NORTH AMERICA PRENATAL TESTING MARKET 2015-2022 ($BILLION)
  • 41 THE U.S. PRENATAL TESTING & NEWBORN SCREENING, 2015-2022 ($BILLION)
  • 42 THE U.S. PRENATAL TESTING & NEWBORN SCREENING, 2015-2022 ($BILLION)
  • 43 EUROPEAN PRENATAL TESTING & NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 44 EUROPEAN PRENATAL TESTING & NEWBORN SCREENING MARKET, BY SUB-REGION, 2015-2022 ($BILLION)
  • 45 EUROPEAN PRENATAL TESTING & NEWBORN SCREENING MARKET, BY COUNTRIES, 2015-2022 ($BILLION)
  • 46 APAC: COUNTRY-WISE CAGR OF PRENATAL TESTING AND NEWBORN SCREENING MARKET
  • 47 APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 48 APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 49 CHINA'S MARKET SHARE IN APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET-2015
  • 50 CHINA'S PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 51 INDIA'S MARKET SHARE IN APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET-2015
  • 52 INDIA'S PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 53 CHALLENGES FOR PRENATAL TESTING AND NEWBORN SCREENING IN INDIA
  • 54 REGION-WISE CAGR OF PRENATAL TESTING AND NEWBORN SCREENING MARKET
  • 55 ROW PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 56 ROW PRENATAL TESTING AND NEWBORN SCREENING MARKET, BY SUB-REGION, 2015-2022 ($BILLION)
  • 57 ROW PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
  • 58 ILLUMINA, INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
  • 59 ILLUMINA, INC. - FINANCIALS BY BUSINESS SEGMENTS, 2013-2015, ($MILLION)
  • 60 ILLUMINA, INC. - FINANCIALS BY GEOGRAPHY, 2013-2014 ($MILLION)
  • 61 ILLUMINA, INC. - SWOT ANALYSIS
  • 62 LABCORP- OVERALL FINANCIALS, 2013-2015, ($MILLION)
  • 63 LABCORP- FINANCIALS BY BUSINESS SEGMENTS, 2013-2014, ($MILLION)
  • 64 LABCORP- SWOT ANALYSIS
  • 65 NATUS MEDICAL INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
  • 66 NATUS MEDICAL INC. - FINANCIALS BY PRODUCT TYPE, 2013-2015, ($MILLION)
  • 67 NATUS MEDICAL INC. - FINANCIALS BY GEOGRAPHY, 2013-2015, ($MILLION)
  • 68 NATUS MEDICAL INC. - FINANCIALS BY END MARKET, 2013-2015, ($MILLION
  • 69 NATUS MEDICAL INC. - FINANCIALS BY NEWBORN CARE (2015)
  • 70 NATUS MEDICAL INCORPORATED- RECENT DEVELOPMENTS
  • 71 PERKINELMER, INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
  • 72 PERKINELMER, INC. - FINANCIALS BY BUSINESS SEGMENTS, 2013-2015, ($MILLION)
  • 73 PERKINELMER, INC. - FINANCIALS BY GEOGRAPHY, 2013-2014, ($MILLION)
  • 74 QUEST DIAGNOSTICS INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
  • 75 QUEST DIAGNOSTICS INC. - FINANCIALS BY BUSINESS SEGMENTS, 2013-2014, ($MILLION)
  • 76 QUEST DIAGNOSTICS INC. - SWOT ANALYSIS

LIST OF TABLES

  • 1 CARRIER FREQUENCIES BASED ON ETHNIC ORIGIN
  • 2 ASSOCIATIONS, CONSORTIUM AND REGULATORY BODIES
  • 3 PATENT ANALYSIS
  • 4 TYPES OF GENETIC DISEASES IN FETUSES: AN OVERVIEW
  • 5 SCREENING METHODS: SOME EXAMPLES
  • 6 DIAGNOSIC TECHNIQUES: SOME EXAMPLES
  • 7 TARGETED DISORDERS IN NEWBORN SCREENING
  • 8 INCIDENCE RATE FOR SOME GENETIC DISEASES IN INDIA
  • 9 ILLUMINA, INC. - RECENT DEVELOPMENTS
  • 10 LABCORP- RECENT DEVELOPMENTS
  • 11 NATUS MEDICAL INCORPORATED- RECENT DEVELOPMENTS
  • 12 PERKINELMER, INC. - RECENT DEVELOPMENTS
  • 13 PERKINELMER, INC. - SWOT ANALYSIS
  • 14 QUEST DIAGNOSTICS INC. - RECENT DEVELOPMENTS
  • 15 OTHER EMERGING PLAYERS
  • 16 LIST OF ACCRONYMS
Back to Top